The Report Guru

The report " IVD Quality Control Market size is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period. IVD testing plays a significant role in clinical decision-making. Over the years, IVD quality control products and procedures have become mandatory in accredited clinical or medical laboratories. The applications of IVD quality control products have also widened over the years, with a number of quality controls currently available in the market for clinical chemistry, hematology, molecular diagnostics, immunochemistry, coagulation, and microbiology. To ensure technological competitiveness, companies are continuously launching innovative and advanced quality control products in the market for a variety of applications. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 The growth of the IVD quality control market is primarily driven by the rising number of accredite...

According to research report the global In Vitro Diagnostics Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. The market for IVD quality control is primarily driven by increasing demands for laboratory accreditation, as well as the rising number of accredited laboratories and growing adoption of third-party quality controls. However, the lack of regulations for clinical laboratory accreditation in several emerging countries will challenge market growth. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Based on product and service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services. In 2019, quality control products accounted for the largest share of the global IVD quality control market. Growth in the quality control products market can be attributed to th...

 According to research report the IVD Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Some of the factors driving the growth of the In Vitro Diagnostics Quality Control Market are increasing number of accredited clinical laboratories, rising demand for external quality assurance support, and growing adoption of third-party quality controls. The molecualr diagnostics segment is expected to grow at the highest CAGR during the forecast period. Based on applications, the IVD quality control market is segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other applications (ESR, urine chemistry, immunology, cardiac assessment, and blood morphology). The molecular diagnostics segment is expected to grow at the ...

According to research report the global IVD Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Key players are focusing on increasing their presence in this growing market through both organic as well as inorganic growth strategies, such as product launches, agreements, partnerships, collaborations, and expansions. Due to the intense competition in this market, various market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets. Randox Laboratories Ltd. (UK) held the second-largest share of the global IVD quality control market. Its position in the market can be attributed to its robust product portfolio and a strong network of partners across the world. Under its flagship brands ‘Acusera’ and ‘RIQAS,’ the company offers various quality controls a...

Some of the factors driving the growth of the In Vitro Diagnostics Quality Control Market are increasing number of accredited clinical laboratories, rising demand for external quality assurance support, and growing adoption of third-party quality controls. According to research report the global IVD Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 The prominent players in this In Vitro Diagnostics Quality Control Market are Bio-Rad Laboratories Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific Inc. (US), Technopath Clinical Diagnostics (Ireland), Bio-Techne Corporation (US), Fortress Diagnostics (UK), SeraCare Life Sciences Inc. (US), SERO AS (Norway), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), and Abbott Laboratories Inc. (US). Bio-...

  According to research report the global IVD Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 The IVD quality control market is primarily driven by increasing demands for laboratory accreditation, as well as the rising number of accredited laboratories and growing adoption of third-party quality controls. However, the lack of regulations for clinical laboratory accreditation in several emerging countries will challenge market growth. On the basis of type, the quality control products market is segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls, and other controls (controls manufactured from spinal fluid, lipoprotein extracts, and immunoproteins). The serum/plasma-based controls segment is expected to account for the largest market share in 201...

 According to research report the global IVD Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period. Some of the factors driving the growth of the IVD Quality Control Market are increasing number of accredited clinical laboratories, rising demand for external quality assurance support, and growing adoption of third-party quality controls. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Key players are focusing on increasing their presence in this growing In Vitro Diagnostics Quality Control Market through both organic as well as inorganic growth strategies, such as product launches, agreements, partnerships, collaborations, and expansions. Due to the intense competition in this market, various market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets. Bio-Rad Laboratories Inc. (US) was...

According to research report the global In Vitro Diagnostics Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. The market for IVD quality control is primarily driven by increasing demands for laboratory accreditation, as well as the rising number of accredited laboratories and growing adoption of third-party quality controls. However, the lack of regulations for clinical laboratory accreditation in several emerging countries will challenge market growth. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Based on product and service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services. In 2019, quality control products accounted for the largest share of the global IVD quality control market. Growth in the quality control products market can be attributed to t...